ENNUMO Trademark

Trademark Overview

On Tuesday, February 26, 2019, a trademark application was filed for ENNUMO with the United States Patent and Trademark Office. The USPTO has given the ENNUMO trademark a serial number of 88316121. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 19, 2022. This trademark is owned by Accord BioPharma, Inc.. The ENNUMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production
ennumo

General Information

Serial Number88316121
Word MarkENNUMO
Filing DateTuesday, February 26, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAccord BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameAccord BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Monday, September 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 28, 2022SOU EXTENSION 5 GRANTED
Thursday, January 20, 2022SOU EXTENSION 5 FILED
Friday, January 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 20, 2022TEAS EXTENSION RECEIVED
Wednesday, July 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 19, 2021SOU EXTENSION 4 GRANTED
Monday, July 19, 2021SOU EXTENSION 4 FILED
Monday, July 19, 2021TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 3 GRANTED
Thursday, February 11, 2021SOU EXTENSION 3 FILED
Thursday, February 11, 2021TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 17, 2020SOU EXTENSION 2 GRANTED
Friday, July 17, 2020SOU EXTENSION 2 FILED
Friday, July 17, 2020TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 10, 2020SOU EXTENSION 1 GRANTED
Friday, January 10, 2020SOU EXTENSION 1 FILED
Friday, January 10, 2020TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2019ASSIGNED TO EXAMINER
Sunday, March 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 1, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

ennumo white blood cell production stimulating used preparations namely pharmaceuticals pharmaceutical